NLC Health Ventures is a prominent healthtech venture builder and early-stage investor based in Amsterdam, Netherlands. The firm specializes in identifying, building, and scaling transformative health innovations, bridging the gap between scientific discoveries and market-ready solutions to improve patient care. Since its inception in 2015, NLC has evaluated over 20,000 healthtech inventions and built more than 100 ventures across various therapeutic areas, including cardiovascular, orthopedics & spine, therapeutics, and new markets. The company operates four captive funds and has raised over €160 million for its ventures, impacting more than 2.4 million patients globally. NLC's funds are SFDR9 compliant, adhering to strict impact regulations, and the firm is a certified B Corp, supporting UN Sustainable Development Goals 3, 9, and 17.
Is NLC the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with NLC, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Pre-seed, Seed
First ticket size
€0 - €100,000
When engaging NLC Health Ventures, founders should highlight the clinical validation and scalability of their healthtech solution, as well as its potential for real-world patient impact. Demonstrating a clear pathway from scientific discovery to commercial application, with a focus on regulatory readiness and measurable health outcomes, will resonate with their hands-on, venture-building approach. Emphasize your team's domain expertise and readiness to collaborate closely with NLC's operational and technical resources to accelerate market entry and adoption.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.